Joel Solomon Zev Schneider - Mar 14, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Chief Operating Officer
Signature
/s/ Erin P. Brennan as attorney-in-fact for Joel Solomon Zev Schneider
Stock symbol
SLDB
Transactions as of
Mar 14, 2022
Transactions value $
-$33,554
Form type
4
Date filed
3/15/2022, 05:12 PM
Previous filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Sale -$16.8K -15.2K -5.71% $1.10 252K Mar 14, 2022 Direct F1, F2
transaction SLDB Common Stock Sale -$16.8K -15.3K -6.07% $1.10 236K Mar 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F2 Reflects a correction as to the number of securities previously reported in Column 5 of Table I due to an arithmetical error.